FULC
Fulcrum Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.85
+0.26%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-27.4%
Return on equity
-26.2%
Return on assets
-27.4%
Return on invested capital
0.00x
Asset turnover
-$65.8M
Cash from operations
$4.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026